Elizabeth Plimack
Fox Chase Cancer Center

Last Updated On 4/1/2022 5:30:50 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Merck
Recipient: You
Company: Seattle Genetics
Recipient: You
Company: Pfizer
Recipient: You
Company: Infinity Pharmaceuticals
Recipient: You
Company: MEI Pharma
Recipient: You
Company: AstraZeneca/MedImmune
Recipient: You
Company: Astellas Pharma
Recipient: You
Company: Aveo
Recipient: You
Company: Bristol-Myers Squibb/Medarex
Recipient: You
Company: Calithera Biosciences
Recipient: You
Company: Calithera Biosciences
Recipient: You
Company: Genentech
Recipient: You
Company: Janssen
Recipient: You
Company: Pfizer
Recipient: You
Company: Regeneron
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Merck Sharp & Dohme
Recipient: Your Institution
Company: Astellas Pharma
Recipient: Your Institution
Company: Genentech/Roche
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: U.S. Patent No.: 14/588,503, Filed 1/2/2015.
Recipient: Your Institution

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
Open Payments URL: https://openpaymentsdata.cms.gov/physician/66377